103 related articles for article (PubMed ID: 10921326)
1. [Multiple exostoses].
Toguchida J; Nagayama S
Nihon Rinsho; 2000 Jul; 58(7):1473-8. PubMed ID: 10921326
[TBL] [Abstract][Full Text] [Related]
2. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
Stickens D; Brown D; Evans GA
Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
[TBL] [Abstract][Full Text] [Related]
3. [From gene to disease; hereditary multiple exostoses].
Wuyts W; Bovée JV; Hogendoorn PC
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
Wuyts W; Van Hul W
Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses.
Raskind WH; Conrad EU; Matsushita M; Wijsman EM; Wells DE; Chapman N; Sandell LJ; Wagner M; Houck J
Hum Mutat; 1998; 11(3):231-9. PubMed ID: 9521425
[TBL] [Abstract][Full Text] [Related]
6. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
[TBL] [Abstract][Full Text] [Related]
7. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
[TBL] [Abstract][Full Text] [Related]
8. Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses.
Philippe C; Porter DE; Emerton ME; Wells DE; Simpson AH; Monaco AP
Am J Hum Genet; 1997 Sep; 61(3):520-8. PubMed ID: 9326317
[TBL] [Abstract][Full Text] [Related]
9. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
[TBL] [Abstract][Full Text] [Related]
11. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.
Chen WC; Chi CH; Chuang CC; Jou IM
J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657
[TBL] [Abstract][Full Text] [Related]
12. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes.
Stickens D; Clines G; Burbee D; Ramos P; Thomas S; Hogue D; Hecht JT; Lovett M; Evans GA
Nat Genet; 1996 Sep; 14(1):25-32. PubMed ID: 8782816
[TBL] [Abstract][Full Text] [Related]
13. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
Hall CR; Cole WG; Haynes R; Hecht JT
Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
[TBL] [Abstract][Full Text] [Related]
14. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
Wuyts W; Radersma R; Storm K; Vits L
Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.
Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT
J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of hereditary multiple exostoses in the Chinese.
Xu L; Xia J; Jiang H; Zhou J; Li H; Wang D; Pan Q; Long Z; Fan C; Deng HX
Hum Genet; 1999; 105(1-2):45-50. PubMed ID: 10480354
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlation in hereditary multiple exostoses.
Francannet C; Cohen-Tanugi A; Le Merrer M; Munnich A; Bonaventure J; Legeai-Mallet L
J Med Genet; 2001 Jul; 38(7):430-4. PubMed ID: 11432960
[TBL] [Abstract][Full Text] [Related]
18. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas.
Pedrini E; De Luca A; Valente EM; Maini V; Capponcelli S; Mordenti M; Mingarelli R; Sangiorgi L; Dallapiccola B
Hum Mutat; 2005 Sep; 26(3):280. PubMed ID: 16088908
[TBL] [Abstract][Full Text] [Related]
19. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.
McCormick C; Duncan G; Goutsos KT; Tufaro F
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):668-73. PubMed ID: 10639137
[TBL] [Abstract][Full Text] [Related]
20. Mutation screening of the EXT genes in patients with hereditary multiple exostoses in Taiwan.
Shi YR; Wu JY; Hsu YA; Lee CC; Tsai CH; Tsai FJ
Genet Test; 2002; 6(3):237-43. PubMed ID: 12490068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
